This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Rosiglitazone

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Liraglutide Has Low CVD Risk but May Be Blocked for Approval

Posted: Wednesday, April 15, 2009

Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of animal studies linking the injection to thyroid cancer.

Thiazolidinediones Increase Fracture Risk in Women

Posted: Friday, December 12, 2008

Two widely prescribed type 2 diabetes drugs have recently been shown to increase risk of fractures in women, following long-term usage.

Rosiglitazone More Dangerous Than Pioglitazone for Elderly Diabetics

Posted: Monday, November 24, 2008

Two oral medications for type 2 diabetes, rosiglitazone and pioglitazone, have both been shown to have benefit and potentially high risk. A recent study has concluded that rosigilitazone is significantly more dangerous for older diabetics.

Combo of Diabetes Drugs Increases Mortality

Posted: Thursday, August 21, 2008

Combination treatment for type 2 diabetes using two classes of drugs -- metformin and sulfonylureas -- may increase the risk of hospitalization for cardiovascular disease and mortality, according to a new report.

Diabetes Medication May Promote Eye Health

Posted: Wednesday, June 25, 2008

The diabetes medication rosiglitazone has been associated with a reduction in the likelihood of developing the eye disease called proliferative diabetic retinopathy. A study published in the June issue of Archives of Ophthalmology also found that diabetes patients using the drug were less likely to have reductions in visual acuity (or sharpness).

More Evidence of Increased Fractures With Thiazolidinediones

Posted: Wednesday, June 25, 2008

Further evidence that long-term use of the thiazolidinediones rosiglitazone and pioglitazone may increase risk of fractures (particularly of the hip and wrist) has come from a new case-control study.

Medicine Might Help Prevent Diabetic Retinopathy

Posted: Friday, June 13, 2008

Diabetics who take the drug rosiglitazone may significantly decrease the chance of visual impairments and blindness. This drug appears to fend off the common and troubling condition known as diabetic retinopathy.

Glitazones No Better than Older Drugs for Type 2 Diabetes

Posted: Friday, April 18, 2008

The class of glitazone diabetes drugs offer no benefits as monotherapy compared with older, less expensive drugs, according to the authors of an analysis of data from recent clinical trials.

Some Medications by Older Adults Increases Risk of Serious Heart Problems, Death

Posted: Thursday, December 20, 2007

Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study.

Rosiglitazone to Stay on US Market With New Warnings About MI

Posted: Friday, November 23, 2007

The FDA has decided to allow the diabetes drug rosiglitazone (Avandia, GlaxoSmithKline) to stay on the market with increased warnings about the risk of cardiovascular events, while further studies are conducted to investigate the issue. A myocardial infarction warning will be added to the black box warning.